TED Stocking vs. Reparel Garment After Hip Replacement
Condition(s) studied
Investigational drug(s) / intervention(s)
Reparel Bioactive Sleeve: A non-compressive, photobiomodulating sleeve worn on the leg to reduce postoperative pain and swelling.
TED Stocking: Standard-of-care gradient compression stocking used after hip replacement.
Study summary
This randomized, prospective study compares the effectiveness of a novel bioactive garment (Reparel Leg Sleeve) versus standard TED compression stockings in reducing postoperative leg swelling, pain, and deep vein thrombosis (DVT) rates following total hip arthroplasty. The study aims to determine whether the bioactive garment improves patient comfort and recovery outcomes compared to traditional stockings.
Eligibility
Primary outcome measure(s)
- Pain Score (VAS) — Postoperative Weeks 2, 6, and 12
Pain will be measured using the Visual Analog Scale (VAS), a standard 0-10 numeric rating scale. Patients will report pain levels during routine postoperative follow-up visits or via validated questionnaires. - HOOS Jr. Score — Postoperative Weeks 6 and 12
The Hip Disability and Osteoarthritis Outcome Score, Junior (HOOS Jr.) evaluates hip function and patient-reported symptoms following total hip arthroplasty. - VR-12 Score — Postoperative Week 12
The Veterans RAND 12-Item Health Survey (VR-12) evaluates patient-reported physical and mental health status. - HSS Satisfaction Score — Postoperative Week 12
The Hospital for Special Surgery (HSS) Satisfaction Score assesses patient satisfaction following hip replacement surgery. - Forgotten Joint Score — Postoperative Week 12
The Forgotten Joint Score measures the extent to which patients are aware of their hip joint during daily activities, reflecting functional recovery.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Institute for Joint Restoration | Fremont | California |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07246200 on ClinicalTrials.gov ↗ ← All trials in the USA